TINA OVERSTREET: Open Payments
NPI 1417227745 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 33 payments from 11 companies in 2025. Trend: 2023 $49 · 2024 $386 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $179 |
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Sumitomo Pharma America, Inc. | 4 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| Corcept Therapeutics | 2 | $62 |
| Lilly USA, LLC | 3 | $52 |
| SHIELD THERAPEUTICS INC | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: GEMTESA, Kerendia, Ozempic, AIRSUPRA, Wegovy, Korlym, FARXIGA, MOUNJARO.
Industry payments across CA — which companies pay providers there.
